Colin Lightfoot

Colin Lightfoot

B.Sc. Biomedical Science, M.Sc. Infection and Immunity

Colin graduated from the University of Chester with a B.Sc. in Biomedical Science in 2020. Since completing his undergraduate degree, he worked for NHS England as an Associate Practitioner, responsible for testing inpatients for COVID-19 on admission.

See more

Recently Colin was a Study Assistant for Perfectus Biomed, where he grew cell lines and viruses for the testing of mainly commercial cleaning products. He recently completed an M.Sc. in Infection and Immunity at The University of Chester, where his main research focus was antibiotic resistance and the possibility of combatting this with bacteriophage therapy.

See less

Articles from Colin

SARS-CoV-2 and pandemic chilblains

SARS-CoV-2 and pandemic chilblains

A ferritin nanoparticle candidate vaccine for COVID

A ferritin nanoparticle candidate vaccine for COVID

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

Biological timeline of COVID-19 immune recovery described in new research

Biological timeline of COVID-19 immune recovery described in new research

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Response to COVID-19 boosters in seronegative multiple sclerosis patients